Literature DB >> 19487284

Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.

Tanja Holopainen1, Huilian Huang, Caiping Chen, Kyung Eun Kim, Luqing Zhang, Fei Zhou, Wencan Han, Chaojun Li, Jun Yu, Jun Wu, Gou Young Koh, Kari Alitalo, Yulong He.   

Abstract

The angiopoietin-1 (Ang1)/Tie2 signaling pathway is known to play an important role in the regulation of vascular maturation and maintenance of vessel integrity. In this study, we have investigated the effect of systemic Tie2 activation or inhibition on tumor growth and metastasis. We found that treatment with Ang1 delivered via an adenoviral vector promoted s.c. implanted tumor metastasis to the lungs. Ang1 treatment did not significantly increase vascular density in the tumors but induced enlargement of blood vessels in both the tumor and normal tissues, which increased tumor cell dissemination into the blood circulation. Ang1 also enhanced the formation of metastatic foci in the lungs when tumor cells were injected into the circulation via the tail vein. The effect of Ang1 on metastasis was validated by a simultaneous treatment with a soluble form of Tie2 (sTie2), which led to the suppression of Ang1-induced increase of tumor metastasis. Furthermore, using a highly metastatic tumor model, we confirmed that systemic treatment with sTie2 suppressed tumor metastasis to the lungs and lymph nodes, whereas tumor-associated angiogenesis and lymphangiogenesis were not significantly affected. This suggests that the Ang1/Tie2 signals contribute to tumor progression by increasing vascular entry and exit of tumor cells to facilitate tumor dissemination and establishment of metastases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487284     DOI: 10.1158/0008-5472.CAN-08-4654

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Targeting the ANGPT-TIE2 pathway in malignancy.

Authors:  Hanhua Huang; Abhijit Bhat; Gary Woodnutt; Rodney Lappe
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

2.  Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.

Authors:  Melissa K Brunckhorst; Hui Wang; Rong Lu; Qin Yu
Journal:  Cancer Res       Date:  2010-09-07       Impact factor: 12.701

3.  Automated network analysis identifies core pathways in glioblastoma.

Authors:  Ethan Cerami; Emek Demir; Nikolaus Schultz; Barry S Taylor; Chris Sander
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

Review 4.  Targeting angiogenesis in squamous non-small cell lung cancer.

Authors:  Bilal Piperdi; Amartej Merla; Roman Perez-Soler
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

Review 5.  Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

Authors:  A M Isidori; M A Venneri; D Fiore
Journal:  J Endocrinol Invest       Date:  2016-06-25       Impact factor: 4.256

6.  Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway.

Authors:  Ke Ye; Jindong Li; Xinying Li; Shi Chang; Zhejia Zhang
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

7.  Molecular regulation of lymphangiogenesis in development and tumor microenvironment.

Authors:  Taotao Li; Jianfeng Yang; Quansheng Zhou; Yulong He
Journal:  Cancer Microenviron       Date:  2012-08-04

8.  Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.

Authors:  Sigve Andersen; Tom Donnem; Khalid Al-Shibli; Samer Al-Saad; Helge Stenvold; Lill-Tove Busund; Roy M Bremnes
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

9.  Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.

Authors:  Tanja Holopainen; Pipsa Saharinen; Gabriela D'Amico; Anita Lampinen; Lauri Eklund; Raija Sormunen; Andrey Anisimov; Georgia Zarkada; Marja Lohela; Hanna Heloterä; Tuomas Tammela; Laura E Benjamin; Seppo Ylä-Herttuala; Ching Ching Leow; Gou Young Koh; Kari Alitalo
Journal:  J Natl Cancer Inst       Date:  2012-02-17       Impact factor: 13.506

Review 10.  Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.

Authors:  Kabir A Khan; Florence Th Wu; William Cruz-Munoz; Robert S Kerbel
Journal:  EMBO Mol Med       Date:  2021-06-14       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.